0.92
+0.0399(+4.53%)
Currency In USD
| Previous Close | 0.88 |
| Open | 0.88 |
| Day High | 0.95 |
| Day Low | 0.86 |
| 52-Week High | 7.98 |
| 52-Week Low | 0.73 |
| Volume | 102,331 |
| Average Volume | 101,840 |
| Market Cap | 1.67M |
| PE | -0.15 |
| EPS | -6.09 |
| Moving Average 50 Days | 1.04 |
| Moving Average 200 Days | 1.94 |
| Change | 0.04 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $0.51 as of March 07, 2026 at a share price of $0.92. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $0.43 as of March 07, 2026 at a share price of $0.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
Newsfile
7 hours ago
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of disease-modifying small molecule drug candidates that ta
InMed Announces Results of 2025 Annual General and Special Meeting
Newsfile
Dec 18, 2025 1:00 AM GMT
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for disea
InMed Provides Update on BayMedica Commercial Business
Newsfile
Dec 12, 2025 10:31 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for dise